Author Guidelines

Manuscript Submission

At present, all manuscripts to The Journal of Haemophilia Practice should be submitted via email to mike@haemnet.com.

Each submission should include a covering letter, signed on behalf of all co-authors by the corresponding author, stating that the manuscript is original and has not been published elsewhere or is currently under consideration by another journal. We accept that the manuscript may have been submitted to another journal previously.

The corresponding author should state clearly whether or not there are any conflicts of interest.

An Open Access Statement will be added to each manuscript.

Manuscript Types

The Journal of Haemophilia Practice accepts

  • Original research
  • Case reports
  • Case Series
  • Reviews in any field of bleeding disorders that are of relevance to current clinical practice.
  • Clinical Updates that describe current advances in any clinical field related tobleeding disorders.
  • Editorials that address a particular topic of current interest

All articles should be submitted with a short abstract. For original articles, the abstract should be structured using the following headings: Background, Aims, Materials and Methods, Results and Conclusions.

Submissions should also include 3-6 keywords for indexing.

We do not specify word counts for articles, but as a guide, shorter items (such as case reports and small cohort studies) range from 1000 to 3000 words. Reviews, larger studies and qualitative studies, which require explanation of methodologies, may range from 3000 to 7,500 words.

Generic drug names should be used in text, tables, and figures.

Suppliers of drugs, equipment, and other brand-name material should be credited in parentheses (company, brand name, city, state, country).

Reference Style

The title of journals should be abbreviated according to the style of Index Medicus, and spelled out in full if not listed in Index Medicus.

Examples of different reference styles are as follows:

  • Reference to an article: Khair K, Holland M, Vidler V, Loran C, Harrington C. Why don't haemophilia nurses do research? Haemophilia 2012; 18: 540-3.
  • Reference to a book: Jones P. Living with Haemophilia. 2002. Oxford: Oxford University Press.
  • Reference to chapter in a book: Escobar MA, Roberts HR. Less common congenital disorders of hemostasis. In: Kitchens CS ed. Consultative Hemostasis and Thrombosis, 3rd edn. Philadelphia, PA: W.B. Saunders Company; 2013: in press.
  • Reference to a webpage European Medicines Agency (EMA). European Public Assessment Report (EPAR) NovoSeven Summary for the Public. 2009. Available from http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000074/human_med_000936.jsp&mid=WC0b01ac058001d124 (accessed 9 September 2013).

Authorship

Authorship should be based on the following four criteria:

  • Substantial contributions to the conception or design of the work AND
  • Drafting the work or revising it critically for important intellectual content AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in its entirety.

The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. Authors should not submit the same manuscript simultaneously to more than one journal, in the same or different language.